Assignee profile:

ZYMOGENETICS, INC.

City:

Seattle, Washington

Country:

United States

Published Applications:

390

Last publication date:

2021-05-13

Patent Grants:

361

Last grant date:

2023-01-03

Quarterly ZYMOGENETICS, INC. Patent Applications

Top Inventors for applications by ZYMOGENETICS, INC.

These are the the leading inventors for applications assigned to ZYMOGENETICS, INC.:

Recent patent applications by ZYMOGENETICS, INC.

ZYMOGENETICS, INC. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-05-13
US20210139577A1
Chemistry; metallurgy

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#2 | 2020-08-20 āœ… Patent 11,542,327 granted on 2023-01-03
US20200262913A1
Chemistry; metallurgy

Methods of treating pruritic disease with IL-31 monoclonal antibodies

#3 | 2020-07-30 āœ… Patent 11,312,779 granted on 2022-04-26
US20200239581A1
Chemistry; metallurgy

Methods of treating prurigo nodularis using anti-IL-31RA antibody compositions

#4 | 2017-11-02 āœ… Patent 9,982,044 granted on 2018-05-29
US20170313768A1
Chemistry; metallurgy

Method of treating pruritus with IL-31 monoclonal antibody formulations

#5 | 2017-08-17 āœ… Patent 10,023,656 granted on 2018-07-17
US20170233498A1
Chemistry; metallurgy

Methods of treating inflammation using IL-17A and IL-17F cross-reactive monoclonal antibodies

#6 | 2017-05-11 āœ… Patent 9,822,177 granted on 2017-11-21
US20170129952A1
Chemistry; metallurgy

Method of reducing pruritus using IL-31 monoclonal antibodies

#7 | 2016-12-29 āœ… Patent 9,994,634 granted on 2018-06-12
US20160376362A1
Chemistry; metallurgy

Use of an IL-17/IL-23 bispecific antibody for treating inflammation

#8 | 2016-10-27 āœ… Patent 9,738,715 granted on 2017-08-22
US20160311898A1
Chemistry; metallurgy

IL-31 monoclonal antibody formulations

#9 | 2016-10-27 āœ… Patent 10,000,563 granted on 2018-06-19
US20160311897A1
Chemistry; metallurgy

Monoclonal antibodies that bind both IL-17A and IL-17F

#10 | 2016-08-04 āœ… Patent 9,631,022 granted on 2017-04-25
US20160222123A1
Chemistry; metallurgy

Method treating neuronal tissue inflammation using an IL-31RA monoclonal antibody

#11 | 2016-08-04 āœ… Patent 9,631,021 granted on 2017-04-25
US20160222103A1
Chemistry; metallurgy

Use of an IL-31 monoclonal antibody for antagonizing signal transduction in spinal cord cells

#12 | 2016-03-03 āœ… Patent 9,738,700 granted on 2017-08-22
US20160060323A1
Chemistry; metallurgy

ZCYTOR17 heterodimeric cytokine receptor

#13 | 2016-02-25 āœ… Patent 9,663,572 granted on 2017-05-30
US20160053008A1
Chemistry; metallurgy

Antibodies that bind both IL-17A and IL-17F

#14 | 2016-02-25
US20160051671A1
Human necessities

COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE

#15 | 2015-07-16 āœ… Patent 9,464,134 granted on 2016-10-11
US20150197566A1
Chemistry; metallurgy

Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19

#16 | 2015-07-02 āœ… Patent 9,624,296 granted on 2017-04-18
US20150183869A1
Chemistry; metallurgy

Polynucleotides encoding IL-31 monoclonal antibodies

#17 | 2015-01-08 āœ… Patent 9,605,062 granted on 2017-03-28
US20150010946A1
Chemistry; metallurgy

Polynucleotides encoding ZCYTOR17 ligand antibodies

#18 | 2014-11-06 āœ… Patent 9,346,878 granted on 2016-05-24
US20140328844A1
Chemistry; metallurgy

Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins

#19 | 2014-09-18
US20140271645A1
Chemistry; metallurgy

METHOD FOR TREATING INFLAMMATION

#20 | 2014-08-07 āœ… Patent 9,725,506 granted on 2017-08-08
US20140220014A1
Chemistry; metallurgy

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

#21 | 2014-06-26 āœ… Patent 9,499,598 granted on 2016-11-22
US20140178333A1
Chemistry; metallurgy

Mutants of IL-29

#22 | 2014-05-22 āœ… Patent 9,212,213 granted on 2015-12-15
US20140141485A1
Chemistry; metallurgy

ZCYTOR17 heterodimeric cytokine receptor

#23 | 2014-04-17 āœ… Patent 9,663,566 granted on 2017-05-30
US20140107034A1
Chemistry; metallurgy

Soluble hybrid Fcγ receptors and related methods

#24 | 2014-03-20 āœ… Patent 9,156,909 granted on 2015-10-13
US20140080181A1
Chemistry; metallurgy

Polynucleotides encoding IL-31 monoclonal antibodies

#25 | 2014-01-02
US20140004077A1
Human necessities

METHOD FOR TREATING CERVICAL CANCER

#26 | 2013-12-12 āœ… Patent 9,146,242 granted on 2015-09-29
US20130330339A1
Physics

Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods

#27 | 2013-12-12 āœ… Patent 8,900,578 granted on 2014-12-02
US20130330330A1
Chemistry; metallurgy

Anti-IL-TIF antibodies

#28 | 2013-11-28
US20130315919A1
Chemistry; metallurgy

ANTI-IL-22RA ANTIBODIES

#29 | 2013-11-21 āœ… Patent 8,992,922 granted on 2015-03-31
US20130309235A1
Chemistry; metallurgy

Antagonists of IL-17A, IL-17F, and IL-23P19

#30 | 2013-11-21 āœ… Patent 8,815,238 granted on 2014-08-26
US20130309231A1
Chemistry; metallurgy

Methods for Preparing TACI-immunoglobulin fusion proteins

#31 | 2013-11-14 āœ… Patent 8,728,469 granted on 2014-05-20
US20130302332A1
Human necessities

Method of treating rheumatoid arthritis using anti-IL-20 antibodies

#32 | 2013-11-07 āœ… Patent 8,685,669 granted on 2014-04-01
US20130295611A1
Chemistry; metallurgy

Nucleic acid molecules encoding humanized antibody molecules specific for IL-31

#33 | 2013-10-31 āœ… Patent 8,871,467 granted on 2014-10-28
US20130288304A1
Chemistry; metallurgy

Polynucleotides encoding antibodies that bind both IL-17A and IL-17F

#34 | 2013-08-15 āœ… Patent 8,834,879 granted on 2014-09-16
US20130209467A1
Human necessities

Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis

#35 | 2013-08-08 āœ… Patent 8,926,957 granted on 2015-01-06
US20130203070A1
Physics

Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells

#36 | 2013-08-01 āœ… Patent 8,685,395 granted on 2014-04-01
US20130195855A1
Human necessities

Methods of antagonizing signal transduction in dorsal root ganglion cells

#37 | 2013-07-11 āœ… Patent 8,637,015 granted on 2014-01-28
US20130177562A1
Human necessities

Methods of antagonizing signal transduction in dorsal root ganglion cells

#38 | 2013-06-20 āœ… Patent 8,778,344 granted on 2014-07-15
US20130156695A1
Chemistry; metallurgy

Method of treating atopic dermatitis with antibody to zcytor17 ligand

#39 | 2013-06-06 āœ… Patent 8,759,027 granted on 2014-06-24
US20130143270A1
Chemistry; metallurgy

Production and purification of IL-29

#40 | 2013-06-06 āœ… Patent 8,647,866 granted on 2014-02-11
US20130143265A1
Chemistry; metallurgy

ZCYTOR17 heterodimeric cytokine receptor polynucleotides

#41 | 2013-06-06
US20130142801A1
Human necessities

ANTIBODY TO HUMAN ZCYTO-10 POLYPEPTIDE

#42 | 2013-04-11 āœ… Patent 8,734,776 granted on 2014-05-27
US20130089517A1
Chemistry; metallurgy

Mutants of IL-29

#43 | 2013-02-14 āœ… Patent 8,648,182 granted on 2014-02-11
US20130041143A1
Chemistry; metallurgy

Polynucleotides encoding antibodies to cytokine receptor zcytor17

#44 | 2013-01-31
US20130028894A1
Chemistry; metallurgy

METHODS OF TREATING IL-TIF ASSOCIATED INFLAMMATORY OR IMMUNE DISEASES USING ANTIBODIES AGAINST SOLUBLE ZCYTOR 11 CYTOKINE RECEPTORS

#45 | 2013-01-24 āœ… Patent 8,431,129 granted on 2013-04-30
US20130022599A1
Human necessities

Method of treating fibroproliferative disorders of the heart and lung

#46 | 2013-01-24 āœ… Patent 8,816,053 granted on 2014-08-26
US20130022571A1
Human necessities

Methods for treating viral infection using IL-28 and IL-29 cysteine mutants

#47 | 2012-12-27 āœ… Patent 8,481,288 granted on 2013-07-09
US20120329093A1
Chemistry; metallurgy

Polynucleotides encoding antibodies that bind both IL-17A and IL-17F

#48 | 2012-11-22 āœ… Patent 8,496,936 granted on 2013-07-30
US20120294862A1
Chemistry; metallurgy

Antagonists of IL-17A, IL-17F, and IL-23P19

#49 | 2012-11-15
US20120289684A1
Chemistry; metallurgy

METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS

#50 | 2012-11-08 āœ… Patent 9,388,241 granted on 2016-07-12
US20120282250A1
Chemistry; metallurgy

Anti-human IL-21 antibodies

#51 | 2012-09-06 āœ… Patent 8,361,470 granted on 2013-01-29
US20120225065A1
Chemistry; metallurgy

Methods of treatment using anti-human IL-21 monoclonal antibodies

#52 | 2012-08-16 āœ… Patent 8,383,775 granted on 2013-02-26
US20120208772A1
Chemistry; metallurgy

Cytokine zalpha11 ligand

#53 | 2012-08-16 āœ… Patent 8,372,602 granted on 2013-02-12
US20120208236A1
Chemistry; metallurgy

Methods for producing cytokine receptor ZALPHA11

#54 | 2012-08-16
US20120207761A1
Chemistry; metallurgy

ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION

#55 | 2012-08-16 āœ… Patent 8,409,571 granted on 2013-04-02
US20120207757A1
Chemistry; metallurgy

Methods of antagonizing signal transduction in spinal cord cells

#56 | 2012-07-26 āœ… Patent 8,378,079 granted on 2013-02-19
US20120190830A1
Human necessities

Antibody to human zcyto-10 polypeptide

#57 | 2012-07-26 āœ… Patent 8,524,227 granted on 2013-09-03
US20120189628A1
Chemistry; metallurgy

Anti-IL-TIF antibodies

#58 | 2012-07-12 āœ… Patent 8,226,948 granted on 2012-07-24
US20120177655A1
Chemistry; metallurgy

Anti-human IL-21 monoclonal antibodies

#59 | 2012-07-05 āœ… Patent 8,349,590 granted on 2013-01-08
US20120171723A1
Chemistry; metallurgy

FGF homologs compositions and uses thereof

#60 | 2012-06-21 āœ… Patent 8,536,309 granted on 2013-09-17
US20120156210A1
Chemistry; metallurgy

Methods of producing anti-IL-22RA antibodies

#61 | 2012-06-21 āœ… Patent 8,475,791 granted on 2013-07-02
US20120156209A1
Chemistry; metallurgy

Anti-IL-TIF antibodies and methods of use

#62 | 2012-06-07 āœ… Patent 8,231,866 granted on 2012-07-31
US20120142612A1
Chemistry; metallurgy

Cytokine protein family

#63 | 2012-05-03 āœ… Patent 8,377,438 granted on 2013-02-19
US20120107310A1
Chemistry; metallurgy

Methods of antagonizing signal transduction in spinal cord cells

#64 | 2012-04-12 āœ… Patent 8,562,984 granted on 2013-10-22
US20120089076A1
Chemistry; metallurgy

Methods of treatment using anti-IL-20 antibodies

#65 | 2012-04-05 āœ… Patent 8,298,524 granted on 2012-10-30
US20120083456A1
Human necessities

Methods of using IL-31 to treat chronic obstructive pulmonary disease (COPD)

#66 | 2012-04-05 āœ… Patent 8,242,072 granted on 2012-08-14
US20120082668A1
Chemistry; metallurgy

Methods of treating inflammation using soluble IL-17RA/RC fusion proteins

#67 | 2012-01-26
US20120021518A1
Chemistry; metallurgy

GROWTH FACTOR HOMOLOG ZVEGF4

#68 | 2012-01-26 āœ… Patent 8,318,147 granted on 2012-11-27
US20120020919A1
Human necessities

Use of IL-29 for treating a dengue virus infection

#69 | 2012-01-19 āœ… Patent 8,211,670 granted on 2012-07-03
US20120015403A1
Chemistry; metallurgy

Production and purification of IL-29

#70 | 2012-01-05 āœ… Patent 8,343,476 granted on 2013-01-01
US20120004161A1
Human necessities

Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B

#71 | 2011-12-08 āœ… Patent 8,283,448 granted on 2012-10-09
US20110300101A1
Human necessities

Methods for treating viral infection using IL-28 and IL-29 cysteine mutants

#72 | 2011-12-01 āœ… Patent 8,568,723 granted on 2013-10-29
US20110293514A1
Chemistry; metallurgy

Method of reducing pruritis using IL-31 monoclonal antibodies

#73 | 2011-11-24 āœ… Patent 8,309,692 granted on 2012-11-13
US20110287012A1
Chemistry; metallurgy

Antibodies to cytokine receptor ZCYTOR17

#74 | 2011-09-22 āœ… Patent 8,524,232 granted on 2013-09-03
US20110229473A1
Human necessities

Methods of treatment using taci-immunoglobulin fusion proteins

#75 | 2011-09-08 āœ… Patent 8,658,766 granted on 2014-02-25
US20110217291A1
Chemistry; metallurgy

Soluble hybrid Fcγ receptors and related methods

#76 | 2011-09-01 āœ… Patent 8,388,964 granted on 2013-03-05
US20110212093A1
Chemistry; metallurgy

Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells

#77 | 2011-08-11 āœ… Patent 8,124,378 granted on 2012-02-28
US20110196128A1
Chemistry; metallurgy

Murine zcytor17 ligand polynucleotides

#78 | 2011-08-11 āœ… Patent 8,124,065 granted on 2012-02-28
US20110195916A1
Chemistry; metallurgy

Cytokine Protein Family

#79 | 2011-07-28 āœ… Patent 8,110,372 granted on 2012-02-07
US20110183359A1
Chemistry; metallurgy

Methods for detecting modulators of cytokine receptor zalpha11

#80 | 2011-07-21 āœ… Patent 8,105,591 granted on 2012-01-31
US20110177086A1
Chemistry; metallurgy

Methods of antagonizing signal transduction in dorsal root ganglion cells

#81 | 2011-07-21 āœ… Patent 8,268,773 granted on 2012-09-18
US20110177083A1
Chemistry; metallurgy

Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist

#82 | 2011-07-21 āœ… Patent 8,105,590 granted on 2012-01-31
US20110177072A1
Chemistry; metallurgy

Methods of treating inflammation in neuronal tissue

#83 | 2011-07-21 āœ… Patent 8,313,739 granted on 2012-11-20
US20110177024A1
Chemistry; metallurgy

Use of truncated cysteine IL28 and IL29 Mutants to treat cancers and autoimmune disorders

#84 | 2011-07-14 āœ… Patent 8,222,374 granted on 2012-07-17
US20110172399A1
Chemistry; metallurgy

IL-21 antagonists

#85 | 2011-07-07 āœ… Patent 9,597,062 granted on 2017-03-21
US20110166550A1
Human necessities

Medical devices for delivering fluids during surgery and methods for their use

#86 | 2011-06-30 āœ… Patent 8,333,968 granted on 2012-12-18
US20110159589A1
Chemistry; metallurgy

Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19

#87 | 2011-06-23 āœ… Patent 8,759,066 granted on 2014-06-24
US20110151536A1
Chemistry; metallurgy

Thrombin activator compositions and methods of making and using the same

#88 | 2011-06-23 āœ… Patent 8,124,356 granted on 2012-02-28
US20110151480A1
Chemistry; metallurgy

Methods of purifying zsig33

#89 | 2011-06-23 āœ… Patent 8,133,487 granted on 2012-03-13
US20110150872A1
Chemistry; metallurgy

Soluble heterodimeric cytokine receptor

#90 | 2011-06-02 āœ… Patent 8,241,629 granted on 2012-08-14
US20110130548A1
Chemistry; metallurgy

Anti-human IL-21 monoclonal antibodies

#91 | 2011-05-26 āœ… Patent 9,629,798 granted on 2017-04-25
US20110125089A1
Human necessities

Hemostatic microspheres

#92 | 2011-05-19 āœ… Patent 9,139,651 granted on 2015-09-22
US20110117052A1
Chemistry; metallurgy

Methods of treatment using IL-31RA

#93 | 2011-05-12
US20110110946A1
Chemistry; metallurgy

SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING

#94 | 2011-05-12
US20110110943A1
Chemistry; metallurgy

SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING

#95 | 2011-04-07 āœ… Patent 8,124,739 granted on 2012-02-28
US20110082094A1
Human necessities

Antibody to human Zcyto10 polypeptide

#96 | 2011-04-07 āœ… Patent 8,287,866 granted on 2012-10-16
US20110081344A1
Chemistry; metallurgy

Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors

#97 | 2011-04-07 āœ… Patent 8,790,643 granted on 2014-07-29
US20110081340A1
Chemistry; metallurgy

Methods for treating disease using an anti-IL-21 receptor antibody

#98 | 2011-03-10 āœ… Patent 8,227,579 granted on 2012-07-24
US20110059087A1
Chemistry; metallurgy

IL-23 antagonists

#99 | 2011-03-03 āœ… Patent 7,919,595 granted on 2011-04-05
US20110054148A1
Chemistry; metallurgy

Antibodies to interferon-like protein Zcyto21(IL29)

#100 | 2011-03-03
US20110052588A1
Chemistry; metallurgy

METHOD OF TREATING HEPATOCELLULAR CARCINOMA

Also check out ZymoGenetics, Inc.'s (Seattle, United States) applicant profile with 7 patent applications submitted.

AssigneeID:

5860 āŽ˜